PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | |pulmonary hypertension |
| Sentences | 109 |
| PubMedID- 26299611 | Background: compared to transpulmonary pressure gradient (tppg), diastolic pulmonary vascular pressure gradient (dpg) may be a more sensitive and specific indicator for pulmonary hypertension (ph) due to left heart disease (lhd) with significant pulmonary vascular disease (pvd). |
| PubMedID- 20196994 | pulmonary hypertension due to left heart disease is a pathophysiological and hemodynamic state which is present in a wide range of clinical conditions that affect left heart structures. |
| PubMedID- 20592995 | Advanced valvular heart disease with secondary pulmonary hypertension due to impaired diastolic and/or systolic function of the left ventricle may support the occurrence of csa. |
| PubMedID- 23351920 | Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease. |
| PubMedID- 23932041 | Objectives: the two hemodynamic profiles in left heart disease (lhd) with pulmonary hypertension (ph), passive ph with increased pulmonary venous pressure and reactive ph with increased pulmonary vascular resistance (pvr > 3 wood units, wu), are difficult to distinguish non-invasively. |
| PubMedID- 25737007 | Asymmetric dimethyl-l-arginine is a biomarker for disease stage and follow-up of pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 20862619 | [pulmonary hypertension due to left heart disease: recommendations of the cologne consensus conference 2010]. |
| PubMedID- 23154245 | Thus, we diagnosed pulmonary hypertension owing to left heart disease and complete atrioventricular block that resulted from hcq toxicity. |
| PubMedID- 24736644 | [32] although these lesions resemble plexiform lesions typical for pulmonary artery hypertension, patients with pulmonary hypertension due to left heart disease and/or lung disease, which represent the majority of ph patients do not present with plexiform lesions. |
| PubMedID- 24936542 | Objective: to investigate preoperative and postoperative blood levels of soluble intercellular and vascular cell adhesion molecules (sicam-1, svcam-1) in patients with and without pulmonary hypertension (pah) due to congenital heart disease and left to right (l-r) shunt and to determine whether these molecules can be used as reliable prognostic markers of endothelial activity to predict surgical outcomes. |
| PubMedID- 23098893 | 5'utr repeat polymorphisms of the bmpr2 gene in children with pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 24355634 | pulmonary hypertension due to left heart diseases. |
| PubMedID- 24826287 | Heart transplantation in a 14-year-old boy in the presence of severe out-of-proportion pulmonary hypertension due to restrictive left heart disease: a case report. |
| PubMedID- 20646483 | [surgical treatment strategies for congenital heart disease with pulmonary hypertension]. |
| PubMedID- 24081196 | The effects of perioperative inhaled iloprost on pulmonary hypertension with congenital heart disease. |
| PubMedID- 23213519 | pulmonary hypertension due to left heart disease (clinical group 2) is defined as postcapillary (pulmonary capillary wedge pressure ≥ 15 mmhg) while precapillary (pulmonary capillary wedge pressure ≤ 15 mmhg) pulmonary hypertension presents in other groups. |
| PubMedID- 22221972 | pulmonary hypertension due to left heart disease: updated recommendations of the cologne consensus conference 2011. |
| PubMedID- 26339897 | In ssc, because of the great variability in clinical manifestation, it is possible to identify pulmonary hypertension due to left heart disease, ph due to respiratory disease or pulmonary arterial hypertension. |
| PubMedID- 26203294 | The more frequent cardiac conditions of this group are:chronic left heart diseases with secondary pulmonary hypertension (group 2 of pulmonary hypertension classification10). |
| PubMedID- 20803971 | pulmonary hypertension due to left heart disease, lung disease and/or hypoxia and cteph should be excluded from pah. |
| PubMedID- 23129906 | Objective: to assess endothelial dysfunction and the risk for coronary atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease (chd). |
| PubMedID- 22837856 | [22] enlargement of the right heart chambers, tricuspid regurgitation as a result of this chamber enlargement, flattening or paradoxical motion of the interventricular septum, encroachment of an enlarged right ventricle on the left ventricular cavity, and impaired left ventricular diastolic dysfunction not the result of primary left ventricular or valvular heart disease are findings in patients with significant pulmonary hypertension. |
| PubMedID- 25011987 | Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. |
| PubMedID- 22169723 | Objective: to explore the effect of unidirectional valved patch (uvp) for congenital heart disease (chd) with severe pulmonary hypertension (ph). |
| PubMedID- 26232475 | Pulmonary arterial hypertension or left heart disease with pulmonary hypertension. |
| PubMedID- 25535690 | The aim of this study was to determine whether baseline characteristics and clinical events associate with mortality in patients with pulmonary hypertension (pah) due to congenital heart disease (chd). |
| PubMedID- 26440237 | Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children. |
| PubMedID- 21191432 | pulmonary hypertension due to left-sided heart disease, hypoxemic lung disease, and thromboembolic disorders are each classified separately. |
| PubMedID- 22015568 | This classification is characterized by division into five groups: pulmonary arterial hypertension (pah); pulmonary hypertension due to left heart disease; pulmonary hypertension due to lung disease and/or hypoxia; chronic thromboembolic pulmonary hypertension; and pulmonary hypertension with unclear and/or multifactorial mechanisms. |
| PubMedID- 25610841 | Patients with symptoms and signs of heart failure with pcwps of 13–15 mmhg and elevated pulmonary artery pressures may pose a diagnostic challenge as they do not fulfill the esc definition of pulmonary hypertension due to left heart disease where a cut-off value of 15 mmhg to differentiate between pre- and post-capillary pulmonary hypertension was used [105]. |
| PubMedID- 22068738 | pulmonary hypertension due to left heart disease (systolic or diastolic dysfunction, valvular disease)3. pulmonary hypertension due to lung diseases and/or hypoxia (such as chronic obstructive pulmonary disease, interstitial lung diseases, and others)4. chronic thrombo-embolic pulmonary hypertension5. |
| PubMedID- 24621657 | Background: pulmonary hypertension (ph) because of left-sided heart disease carries a poor prognosis. |
| PubMedID- 26502478 | The most common cause of ph, termed group 2 ph, is left-sided heart failure and is commonly known as pulmonary hypertension with left heart disease (ph-lhd). |
| PubMedID- 26046840 | Methods: in a prospective cohort of patients with right heart catheterization, we identified 73 adult patients who had pulmonary hypertension due to left heart disease (ph-lhd) associated with hfpef (left ventricular ejection fraction >/=50% by echocardiography); hemodynamically defined as a mean pulmonary artery pressure >/=25 mm hg and pulmonary artery wedge pressure >15 mm hg. |
| PubMedID- 24037633 | pulmonary hypertension associated with left heart disease. |
| PubMedID- 24829371 | pulmonary hypertension in adults with congenital heart disease and eisenmenger syndrome: current advanced management strategies. |
| PubMedID- 26291842 | Palliative senning in the treatment of congenital heart disease with severe pulmonary hypertension. |
| PubMedID- 20450852 | In addition, it contains detailed descriptions of the treatment recommended for patients in whom an elevated systolic pulmonary pressure is discovered on echocardiography, of the differential diagnosis of pulmonary arterial hypertension and pulmonary hypertension associated with left heart disease, and of multifactorial approaches to determining prognosis, which are three of the most actively debated topics today. |
| PubMedID- 20136857 | Methods: eight congenital heart disease patients with pulmonary hypertension were studied and followed up during a 1-year period. |
| PubMedID- 23918108 | World health organization (who) group 2 pulmonary hypertension (ph) due to left-side heart disease (ie, heart failure or left-sided valvular heart disease) is the most common form of ph in western countries. |
| PubMedID- 21069290 | Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. |
| PubMedID- 22313804 | Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. |
| PubMedID- 21875514 | pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. |
| PubMedID- 24267298 | pulmonary hypertension owing to left heart disease. |
| PubMedID- 26471823 | There are several mechanisms of pulmonary hypertension in patients with adult congenital heart disease, and understanding them requires a systematic approach to define the patient's hemodynamics and physiology. |
| PubMedID- 24987253 | The clinical characteristics of the study population including the referral diagnosis are listed in table 1. ventricular septal defect (vsd) was the most common congenital heart disease leading to pulmonary hypertension in this study. |
| PubMedID- 22720870 | +: p < 0.05 in comparison to group 3, pulmonary hypertension owing to left heart disease (ph-lhd). |
| PubMedID- 25650280 | [pulmonary hypertension associated with congenital heart disease and eisenmenger syndrome]. |
| PubMedID- 25006452 | Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures. |
| PubMedID- 25705390 | Controversies in pulmonary hypertension due to left heart disease. |